STAT3 and cancer: These findings also set up a solid basis for us to target the miR-K12-1/IκBα/NF-κB/IL-6/STAT3 oncogenic signaling pathway for the prevention and treatment of KSHV-mediated cancers, for which no effective therapies exist currently.